629 related articles for article (PubMed ID: 25124745)
21. Adeno-associated virus-vectored gene therapy for retinal disease.
Dinculescu A; Glushakova L; Min SH; Hauswirth WW
Hum Gene Ther; 2005 Jun; 16(6):649-63. PubMed ID: 15960597
[TBL] [Abstract][Full Text] [Related]
22. The Future Looks Brighter After 25 Years of Retinal Gene Therapy.
Auricchio A; Smith AJ; Ali RR
Hum Gene Ther; 2017 Nov; 28(11):982-987. PubMed ID: 28825330
[TBL] [Abstract][Full Text] [Related]
23. AAV-mediated gene therapy for retinal disorders: from mouse to man.
Buch PK; Bainbridge JW; Ali RR
Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
[TBL] [Abstract][Full Text] [Related]
24. Dual AAV Vectors for Stargardt Disease.
Trapani I
Methods Mol Biol; 2018; 1715():153-175. PubMed ID: 29188512
[TBL] [Abstract][Full Text] [Related]
25. [Developments in gene delivery vectors for ocular gene therapy].
Khabou H; Dalkara D
Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304
[TBL] [Abstract][Full Text] [Related]
26. Recombinant vectors based on porcine adeno-associated viral serotypes transduce the murine and pig retina.
Puppo A; Bello A; Manfredi A; Cesi G; Marrocco E; Della Corte M; Rossi S; Giunti M; Bacci ML; Simonelli F; Surace EM; Kobinger GP; Auricchio A
PLoS One; 2013; 8(3):e59025. PubMed ID: 23520549
[TBL] [Abstract][Full Text] [Related]
27. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
[TBL] [Abstract][Full Text] [Related]
28. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes.
Lieber A; Steinwaerder DS; Carlson CA; Kay MA
J Virol; 1999 Nov; 73(11):9314-24. PubMed ID: 10516040
[TBL] [Abstract][Full Text] [Related]
29. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for retinal disease.
McClements ME; MacLaren RE
Transl Res; 2013 Apr; 161(4):241-54. PubMed ID: 23305707
[TBL] [Abstract][Full Text] [Related]
31. Novel AAV serotypes for improved ocular gene transfer.
Lebherz C; Maguire A; Tang W; Bennett J; Wilson JM
J Gene Med; 2008 Apr; 10(4):375-82. PubMed ID: 18278824
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy for inherited retinal diseases: progress and possibilities.
Hu ML; Edwards TL; O'Hare F; Hickey DG; Wang JH; Liu Z; Ayton LN
Clin Exp Optom; 2021 May; 104(4):444-454. PubMed ID: 33689657
[TBL] [Abstract][Full Text] [Related]
33. The Landscape of Non-Viral Gene Augmentation Strategies for Inherited Retinal Diseases.
Toualbi L; Toms M; Moosajee M
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652562
[TBL] [Abstract][Full Text] [Related]
34. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer into the mouse retina mediated by an adeno-associated viral vector.
Ali RR; Reichel MB; Thrasher AJ; Levinsky RJ; Kinnon C; Kanuga N; Hunt DM; Bhattacharya SS
Hum Mol Genet; 1996 May; 5(5):591-4. PubMed ID: 8733124
[TBL] [Abstract][Full Text] [Related]
36. [Gene therapy: new developments].
Mohr L; Geissler M
Praxis (Bern 1994); 2002 Dec; 91(51-52):2227-35. PubMed ID: 12564039
[TBL] [Abstract][Full Text] [Related]
37. Production methods for gene transfer vectors based on adeno-associated virus serotypes.
Grimm D
Methods; 2002 Oct; 28(2):146-57. PubMed ID: 12413413
[TBL] [Abstract][Full Text] [Related]
38. The Blunt End: Surgical Challenges of Gene Therapy for Inherited Retinal Diseases.
Davis JL
Am J Ophthalmol; 2018 Dec; 196():xxv-xxix. PubMed ID: 30194931
[TBL] [Abstract][Full Text] [Related]
39. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
[TBL] [Abstract][Full Text] [Related]
40. Retinal gene therapy 1998: summary of a workshop.
Hauswirth WW; McInnes RR
Mol Vis; 1998 Jul; 4():11. PubMed ID: 9675216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
